Skip to main content
Premium Trial:

Request an Annual Quote

Schering-Plough Signs on for Pharsight s Drug Software

NEW YORK, Aug. 14 - The Schering-Plough Research Institute will use Pharsight's Knowledgebase software for drug development, Pharsight said today.

 

The software organizes pharmacokinetic data.

The Schering-Plough Research Institute, based in Kenilworth, NJ, focuses on drug discovery and development. Mountain View, Calif.-based Pharsight develops software for drug development, clinical trials and market modeling.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.